Back | Next |
home / stock / arth / arth message board
Subject | By | Source | When |
---|---|---|---|
Key questions to ask yourself: (1) Does AC5 | Polyphemus | investorshub | 10/25/2022 9:21:19 PM |
Arch presentation at SAWC: https://content.equisolve.net/archtherapeutics/media | Snowy_Owl | investorshub | 10/21/2022 2:25:21 AM |
TN is also good at putting together play-doh presentations.... | blackngold63 | investorshub | 10/19/2022 5:37:25 PM |
They seem to be nice posters though. :o) | Snowy_Owl | investorshub | 10/17/2022 8:18:21 PM |
AC5 has been commercial in US & Europe | Polyphemus | investorshub | 10/17/2022 2:56:12 PM |
Arch had two poster presentations at last | Snowy_Owl | investorshub | 10/17/2022 12:30:11 PM |
I wish I knew | moneymaker290 | investorshub | 10/06/2022 5:46:49 PM |
I really think there is a fraud in | fardu | investorshub | 10/06/2022 5:09:10 PM |
Anyone know what was going on with $ARTH | Snowy_Owl | investorshub | 10/06/2022 12:14:26 PM |
I voted NO on all | moneymaker290 | investorshub | 10/06/2022 3:48:46 AM |
I own close to 10M shares and voted | fardu | investorshub | 10/05/2022 11:21:54 PM |
They are the shareholders that will rule that | moneymaker290 | investorshub | 10/05/2022 9:31:39 PM |
Also, shareholders get a say on executive comp | Snowy_Owl | investorshub | 10/04/2022 8:02:50 PM |
After the 300:1 reverse split, additional shares are | Polyphemus | investorshub | 10/04/2022 6:40:37 PM |
Here's the link to Annual meeting. Voting | Snowy_Owl | investorshub | 10/03/2022 12:16:34 PM |
Good question | moneymaker290 | investorshub | 09/29/2022 11:27:27 PM |
Arch annual meeting was today. Did anyone | Snowy_Owl | investorshub | 09/29/2022 5:55:14 PM |
Snow Owl's comments make sense in most cases. | Polyphemus | investorshub | 09/26/2022 8:23:39 PM |
I wish I had worded my post differently. | Snowy_Owl | investorshub | 09/24/2022 4:20:21 PM |
Novartis Medical Nutrition bought Boost from Meade | blackngold63 | investorshub | 09/24/2022 3:42:10 PM |
News, Short Squeeze, Breakout and More Instantly...
Arch Therapeutics Inc Company Name:
ARTH Stock Symbol:
OTCMKTS Market:
Arch Therapeutics Inc Website:
FRAMINGHAM, Mass., May 06, 2024 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB:ARTH) ("Arch" or the "Company"), a marketer and developer of ...
FRAMINGHAM, Mass., May 06, 2024 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) (“ Arch ” or the “ Company ”), a marketer and developer of novel self-assembling wound care and biosurgical products, today announced that the Company’s fir...
Spark New Zealand Limited ADR (SPKKY) is expected to report for Q1 2024 Taylor Devices Inc. (TAYD) is expected to report for Q1 2024 American Biltrite Inc. (ABLT) is expected to report for quarter end 2023-09-30 Cognetivity Neurosciences Ltd (CGNSF) is expected to report for Q3 2024 ...